bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.07.17.739231

eIF5A is an indispensable protein for eukaryotic cells

Alepuz, P.·Prieto-Diez, S.·Aguilar-Diez, A.·Araque, L.·Peris, D.
View original source ↗Export metadata ↓

Abstract

eIF5A is an evolutionarily conserved protein found in all eukaryotes, and in Archaea and bacteria. It functions as a translation factor promoting ribosomal elongation, and it can also bind to genes in the nucleus and to mRNA. eIF5A is encoded by two paralogous genes in most eukaryotes, with one copy (TIF51A in yeast and EIF5A1 in humans) highly expressed and essential, and the other (TIF51B in yeast and EIF5A2 in humans) repressed in most cells and conditions. eIF5A is linked to viral infection, aging, diabetes and neurodevelopmental disorders. Whilst derepression of the duplicated silent gene EIF5A2 is associated with several cancers, promoting metastasis. To expand our knowledge of eIF5As function, we searched for suppressors of yeast temperature-sensitive mutants of TIF51A, which cannot grow at restrictive temperature. All suppressors contained mutations in the transcriptional repressors Rox1 and Mot3, resulting in the upregulation of the paralogous gene TIF51B. Next, we searched for suppressors of TIF51A temperature-sensitive mutants in yeast lacking the TIF51B gene. The frequency of suppression was 20-times lower and all suppressors were revertants or contained intragenic mutations in the Tif51A protein that conferred stability. Our results suggest that the duplicated eIF5A gene serves as a non-conventional backup system that rescues mutations in the first copy, but acting at the population level. Furthermore, our results expand our understanding of the repression mechanisms that keep the second eIF5A gene silent. Lastly, our results demonstrate that eIF5A is an indispensable protein in eukaryotic cells, whose function cannot be substituted by mutations in other proteins or pathways. Article summaryeIF5A is an evolutionary conserved protein encoded by two paralogous genes in eukaryotes: one highly expressed and essential, and the other silent. eIF5A promotes translation elongation, and its deficiency is linked to diabetes, aging and neurodevelopmental disorders; while derepression of the silent gene promotes metastatic cancers. We isolated suppressors of conditional mutants of the first eIF5A gene in yeast cells. Suppressors either up-regulated the second eIF5A gene or reverted first copy mutations, restoring eIF5A protein levels and survival. Our work deepens our understanding of the eIF5A paralogue gene repression, and demonstrates that eIF5A is an indispensable protein for eukaryotic cells.

Explore related subjects

geneticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Alepuz, P., Prieto-Diez, S., Aguilar-Diez, A., Araque, L., Peris, D.. 2026-07-23. eIF5A is an indispensable protein for eukaryotic cells. https://doi.org/10.64898/2026.07.17.739231

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗
bioRxiv2026

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗
bioRxiv2026

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗